These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2440071)

  • 1. CSF amine metabolites and depression.
    Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H
    Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C
    Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF; Major LF
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
    Gibbons RD; Davis JM
    Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide.
    Agren H
    Psychiatry Res; 1980 Oct; 3(2):225-36. PubMed ID: 6171841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.
    Mann JJ; Malone KM
    Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM
    Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.